Melanoma Targeted Therapies beyond BRAF-Mutant Melanoma: Potential Druggable Mutations and Novel Treatment Approaches

SIMPLE SUMMARY: The management of unresectable and metastatic cutaneous melanoma has substantially improved with the introduction of molecular targeted therapy (BRAF and MEK inhibitors) and immunotherapy (Immune checkpoint inhibitors). The avenue of precision oncology holds promise in melanomas due...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaddour, Karam, Maahs, Lucas, Avila-Rodriguez, Ana Maria, Maamar, Yazan, Samaan, Sami, Ansstas, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616477/
https://www.ncbi.nlm.nih.gov/pubmed/34831002
http://dx.doi.org/10.3390/cancers13225847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616477/
https://www.ncbi.nlm.nih.gov/pubmed/34831002
http://dx.doi.org/10.3390/cancers13225847

Ejemplares similares